PRO-169

· Laboratorios Sophia S.A de C.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRO-169, covering 2026-03-13 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema [Phase 3]